TIP60 Inhibitor TH1834 Reduces Breast Cancer Progression in Xenografts in Mice

OMICS. 2019 Sep;23(9):457-459. doi: 10.1089/omi.2019.0126.

Authors

Mouhamed Idrissou^{1

2}, Gaëlle Judes^{1

2}, Marine Daures^{1

2}, Anna Sanchez^{1

2}, Driss El Ouardi^{1

2}, Sophie Besse², Françoise Degoul², Frédérique Penault-Llorca^{2

3}, Yves-Jean Bignon^{1

2}, Dominique Bernard-Gallon^{1

2}

Affiliations

¹ Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France.
² INSERM-UMR 1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France.
³ Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand, France.

PMID: 31487234
DOI: 10.1089/omi.2019.0126

No abstract available

Keywords: animal research; TH1834; TIP60; breast cancer; drug targets and development; xenografts.

Publication types

Letter

MeSH terms

Animals
Antineoplastic Agents / chemistry
Antineoplastic Agents / pharmacology*
Breast Neoplasms / drug therapy
Breast Neoplasms / pathology
Disease Models, Animal
Enzyme Inhibitors / chemistry
Enzyme Inhibitors / pharmacology*
Female
Humans
Lysine Acetyltransferase 5 / antagonists & inhibitors*
Mice
Xenograft Model Antitumor Assays

Substances

Antineoplastic Agents
Enzyme Inhibitors
KAT5 protein, human
Lysine Acetyltransferase 5